High frequency of tumours in Mulibrey nanism
Mulibrey nanism (MUL) is a monogenic disorder with prenatal-onset growth failure, typical clinical characteristics, cardiopathy and tendency for a metabolic syndrome. It is caused by recessive mutations in the TRIM37 gene encoding for the peroxisomal TRIM37 protein with ubiquitin-ligase activity. In...
Saved in:
| Published in | The Journal of pathology Vol. 218; no. 2; pp. 163 - 171 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Chichester, UK
John Wiley & Sons, Ltd
01.06.2009
Wiley |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0022-3417 1096-9896 1096-9896 |
| DOI | 10.1002/path.2538 |
Cover
| Abstract | Mulibrey nanism (MUL) is a monogenic disorder with prenatal-onset growth failure, typical clinical characteristics, cardiopathy and tendency for a metabolic syndrome. It is caused by recessive mutations in the TRIM37 gene encoding for the peroxisomal TRIM37 protein with ubiquitin-ligase activity. In this work, the frequency and pathology of malignant and benign tumours were analysed in a national cohort of 89 Finnish MUL patients aged 0.7-76 years. The subjects had a clinical and radiological evaluation, and histological and immunohistocemical analyses on specimens obtained from biopsy, surgery or autopsy, were performed. The results show that the MUL patients have disturbed architecture with ectopic tissues and a high frequency of both benign and malignant tumours detectable in several internal organs. A total of 210 tumorous lesions were detected in 66/89 patients (74%). Fifteen malignancies occurred in 13 patients (15%), seven of them in the kidney (five Wilms' tumours), three in the thyroid gland, two gynaecological cancers, one gastrointestinal carcinoid tumour, one neuropituitary Langerhans cell histiocytosis and one case of acute lymphoblastic leukaemia (ALL). Tumours detected by radiology in the liver and other organs mainly comprised strongly dilated blood vessels (peliosis), vascularized cysts and nodular lesions. The lesions showed strong expression of the endothelial cell markers CD34 and CD31 as well as the myocyte marker α-smooth muscle actin (α-SMA). Our findings show that MUL is associated with frequent malignant tumours and benign adenomatous and vascular lesions, as well as disturbed organ development. Copyright © 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. |
|---|---|
| AbstractList | Mulibrey nanism (MUL) is a monogenic disorder with prenatal-onset growth failure, typical clinical characteristics, cardiopathy and tendency for a metabolic syndrome. It is caused by recessive mutations in the TRIM37 gene encoding for the peroxisomal TRIM37 protein with ubiquitin-ligase activity. In this work, the frequency and pathology of malignant and benign tumours were analysed in a national cohort of 89 Finnish MUL patients aged 0.7-76 years. The subjects had a clinical and radiological evaluation, and histological and immunohistocemical analyses on specimens obtained from biopsy, surgery or autopsy, were performed. The results show that the MUL patients have disturbed architecture with ectopic tissues and a high frequency of both benign and malignant tumours detectable in several internal organs. A total of 210 tumorous lesions were detected in 66/89 patients (74%). Fifteen malignancies occurred in 13 patients (15%), seven of them in the kidney (five Wilms' tumours), three in the thyroid gland, two gynaecological cancers, one gastrointestinal carcinoid tumour, one neuropituitary Langerhans cell histiocytosis and one case of acute lymphoblastic leukaemia (ALL). Tumours detected by radiology in the liver and other organs mainly comprised strongly dilated blood vessels (peliosis), vascularized cysts and nodular lesions. The lesions showed strong expression of the endothelial cell markers CD34 and CD31 as well as the myocyte marker alpha-smooth muscle actin (alpha-SMA). Our findings show that MUL is associated with frequent malignant tumours and benign adenomatous and vascular lesions, as well as disturbed organ development.Mulibrey nanism (MUL) is a monogenic disorder with prenatal-onset growth failure, typical clinical characteristics, cardiopathy and tendency for a metabolic syndrome. It is caused by recessive mutations in the TRIM37 gene encoding for the peroxisomal TRIM37 protein with ubiquitin-ligase activity. In this work, the frequency and pathology of malignant and benign tumours were analysed in a national cohort of 89 Finnish MUL patients aged 0.7-76 years. The subjects had a clinical and radiological evaluation, and histological and immunohistocemical analyses on specimens obtained from biopsy, surgery or autopsy, were performed. The results show that the MUL patients have disturbed architecture with ectopic tissues and a high frequency of both benign and malignant tumours detectable in several internal organs. A total of 210 tumorous lesions were detected in 66/89 patients (74%). Fifteen malignancies occurred in 13 patients (15%), seven of them in the kidney (five Wilms' tumours), three in the thyroid gland, two gynaecological cancers, one gastrointestinal carcinoid tumour, one neuropituitary Langerhans cell histiocytosis and one case of acute lymphoblastic leukaemia (ALL). Tumours detected by radiology in the liver and other organs mainly comprised strongly dilated blood vessels (peliosis), vascularized cysts and nodular lesions. The lesions showed strong expression of the endothelial cell markers CD34 and CD31 as well as the myocyte marker alpha-smooth muscle actin (alpha-SMA). Our findings show that MUL is associated with frequent malignant tumours and benign adenomatous and vascular lesions, as well as disturbed organ development. Mulibrey nanism (MUL) is a monogenic disorder with prenatal-onset growth failure, typical clinical characteristics, cardiopathy and tendency for a metabolic syndrome. It is caused by recessive mutations in the TRIM37 gene encoding for the peroxisomal TRIM37 protein with ubiquitin-ligase activity. In this work, the frequency and pathology of malignant and benign tumours were analysed in a national cohort of 89 Finnish MUL patients aged 0.7-76 years. The subjects had a clinical and radiological evaluation, and histological and immunohistocemical analyses on specimens obtained from biopsy, surgery or autopsy, were performed. The results show that the MUL patients have disturbed architecture with ectopic tissues and a high frequency of both benign and malignant tumours detectable in several internal organs. A total of 210 tumorous lesions were detected in 66/89 patients (74%). Fifteen malignancies occurred in 13 patients (15%), seven of them in the kidney (five Wilms' tumours), three in the thyroid gland, two gynaecological cancers, one gastrointestinal carcinoid tumour, one neuropituitary Langerhans cell histiocytosis and one case of acute lymphoblastic leukaemia (ALL). Tumours detected by radiology in the liver and other organs mainly comprised strongly dilated blood vessels (peliosis), vascularized cysts and nodular lesions. The lesions showed strong expression of the endothelial cell markers CD34 and CD31 as well as the myocyte marker α-smooth muscle actin (α-SMA). Our findings show that MUL is associated with frequent malignant tumours and benign adenomatous and vascular lesions, as well as disturbed organ development. Copyright © 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. Mulibrey nanism (MUL) is a monogenic disorder with prenatal‐onset growth failure, typical clinical characteristics, cardiopathy and tendency for a metabolic syndrome. It is caused by recessive mutations in the TRIM37 gene encoding for the peroxisomal TRIM37 protein with ubiquitin‐ligase activity. In this work, the frequency and pathology of malignant and benign tumours were analysed in a national cohort of 89 Finnish MUL patients aged 0.7–76 years. The subjects had a clinical and radiological evaluation, and histological and immunohistocemical analyses on specimens obtained from biopsy, surgery or autopsy, were performed. The results show that the MUL patients have disturbed architecture with ectopic tissues and a high frequency of both benign and malignant tumours detectable in several internal organs. A total of 210 tumorous lesions were detected in 66/89 patients (74%). Fifteen malignancies occurred in 13 patients (15%), seven of them in the kidney (five Wilms' tumours), three in the thyroid gland, two gynaecological cancers, one gastrointestinal carcinoid tumour, one neuropituitary Langerhans cell histiocytosis and one case of acute lymphoblastic leukaemia (ALL). Tumours detected by radiology in the liver and other organs mainly comprised strongly dilated blood vessels (peliosis), vascularized cysts and nodular lesions. The lesions showed strong expression of the endothelial cell markers CD34 and CD31 as well as the myocyte marker α‐smooth muscle actin (α‐SMA). Our findings show that MUL is associated with frequent malignant tumours and benign adenomatous and vascular lesions, as well as disturbed organ development. Copyright © 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. Mulibrey nanism (MUL) is a monogenic disorder with prenatal-onset growth failure, typical clinical characteristics, cardiopathy and tendency for a metabolic syndrome. It is caused by recessive mutations in the TRIM37 gene encoding for the peroxisomal TRIM37 protein with ubiquitin-ligase activity. In this work, the frequency and pathology of malignant and benign tumours were analysed in a national cohort of 89 Finnish MUL patients aged 0.7-76 years. The subjects had a clinical and radiological evaluation, and histological and immunohistocemical analyses on specimens obtained from biopsy, surgery or autopsy, were performed. The results show that the MUL patients have disturbed architecture with ectopic tissues and a high frequency of both benign and malignant tumours detectable in several internal organs. A total of 210 tumorous lesions were detected in 66/89 patients (74%). Fifteen malignancies occurred in 13 patients (15%), seven of them in the kidney (five Wilms' tumours), three in the thyroid gland, two gynaecological cancers, one gastrointestinal carcinoid tumour, one neuropituitary Langerhans cell histiocytosis and one case of acute lymphoblastic leukaemia (ALL). Tumours detected by radiology in the liver and other organs mainly comprised strongly dilated blood vessels (peliosis), vascularized cysts and nodular lesions. The lesions showed strong expression of the endothelial cell markers CD34 and CD31 as well as the myocyte marker alpha-smooth muscle actin (alpha-SMA). Our findings show that MUL is associated with frequent malignant tumours and benign adenomatous and vascular lesions, as well as disturbed organ development. Mulibrey nanism (MUL) is a monogenic disorder with prenatal-onset growth failure, typical clinical characteristics, cardiopathy and tendency for a metabolic syndrome. It is caused by recessive mutations in the TRIM37 gene encoding for the peroxisomal TRIM37 protein with ubiquitin-ligase activity. In this work, the frequency and pathology of malignant and benign tumours were analysed in a national cohort of 89 Finnish MUL patients aged 0.7-76 years. The subjects had a clinical and radiological evaluation, and histological and immunohistocemical analyses on specimens obtained from biopsy, surgery or autopsy, were performed. The results show that the MUL patients have disturbed architecture with ectopic tissues and a high frequency of both benign and malignant tumours detectable in several internal organs. A total of 210 tumorous lesions were detected in 66/89 patients (74%). Fifteen malignancies occurred in 13 patients (15%), seven of them in the kidney (five Wilms' tumours), three in the thyroid gland, two gynaecological cancers, one gastrointestinal carcinoid tumour, one neuropituitary Langerhans cell histiocytosis and one case of acute lymphoblastic leukaemia (ALL). Tumours detected by radiology in the liver and other organs mainly comprised strongly dilated blood vessels (peliosis), vascularized cysts and nodular lesions. The lesions showed strong expression of the endothelial cell markers CD34 and CD31 as well as the myocyte marker α-smooth muscle actin (α-SMA). Our findings show that MUL is associated with frequent malignant tumours and benign adenomatous and vascular lesions, as well as disturbed organ development. |
| Author | Karikoski, Riitta Karlberg, Susann Jalanko, Hannu Mikkola, Sakari Lipsanen-Nyman, Marita Karlberg, Niklas |
| Author_xml | – sequence: 1 fullname: Karlberg, Niklas – sequence: 2 fullname: Karlberg, Susann – sequence: 3 fullname: Karikoski, Riitta – sequence: 4 fullname: Mikkola, Sakari – sequence: 5 fullname: Lipsanen-Nyman, Marita – sequence: 6 fullname: Jalanko, Hannu |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21426833$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19334051$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkc1u1DAURi1URKeFBS8A2YCERFpf_8VeVhXtIA0wEq3KzrITuzUkzmAngnl7MpowCwRi5YXP-ex7vxN0FPvoEHoO-AwwJucbMzycEU7lI7QArESppBJHaDHdkZIyqI7RSc5fMcZKcf4EHYOilGEOC_R2Ge4fCp_c99HFelv0vhjGrh9TLkIsPoxtsMlti2hiyN1T9NibNrtn83mKbq_e3Vwuy9Wn6_eXF6uyZkzIkgpFiaHeAgfAzHsrq6Z2RlrwTglvPRfSS1crb61iEgxVDVMNbYTnFgg9Ra_3uZvUT__Kg-5Crl3bmuj6MWtREcI48P-CTJBKcqAT-GIGR9u5Rm9S6Eza6t-LmIBXM2BybVqfTKxDPnAEGBGS7oLO91yd-pyT87oOgxlCH4dkQqsB610leleJ3lUyGW_-MA6P_4Wd03-E1m3_Der1xc1yNsq9EfLgfh4Mk75NW6IV13cfr_Ua3-Gr1eqLXk_8yz3vTa_NfZpmvP1MMFAMghKQnP4C_7uyBw |
| CODEN | JPTLAS |
| CitedBy_id | crossref_primary_10_1080_15384101_2021_1988289 crossref_primary_10_1016_j_bone_2020_115393 crossref_primary_10_1158_1078_0432_CCR_24_2100 crossref_primary_10_4081_vl_2023_11826 crossref_primary_10_1002_ajmg_a_63638 crossref_primary_10_3389_fonc_2020_590033 crossref_primary_10_1111_liv_15213 crossref_primary_10_1002_path_2552 crossref_primary_10_1002_ajmg_a_38381 crossref_primary_10_1002_cnr2_1512 crossref_primary_10_1083_jcb_202010180 crossref_primary_10_1016_j_ejca_2021_05_014 crossref_primary_10_1038_s41581_019_0112_0 crossref_primary_10_1016_j_cjco_2021_08_012 crossref_primary_10_7554_eLife_62640 crossref_primary_10_1093_omcr_omv065 crossref_primary_10_3390_ijms23031176 crossref_primary_10_1016_j_bbcan_2018_07_004 crossref_primary_10_1186_s40001_021_00482_1 crossref_primary_10_1007_s00467_017_3669_5 crossref_primary_10_1242_bio_016246 crossref_primary_10_1210_er_2018_00166 crossref_primary_10_1007_s00431_013_1962_2 crossref_primary_10_1093_humrep_dey103 crossref_primary_10_1002_pbc_30006 crossref_primary_10_1080_15548627_2018_1463120 crossref_primary_10_1111_cge_14647 crossref_primary_10_3390_ijms20010067 crossref_primary_10_1002_ppul_24518 crossref_primary_10_1002_pbc_30343 crossref_primary_10_1038_s41572_021_00308_8 crossref_primary_10_1158_1078_0432_CCR_17_0710 crossref_primary_10_1097_MED_0000000000000459 crossref_primary_10_3390_cancers14235967 crossref_primary_10_1016_j_ejmg_2016_01_008 |
| Cites_doi | 10.1016/j.yexcr.2005.04.001 10.1016/S0022-3476(76)80008-X 10.1369/jhc.4A6514.2005 10.1007/s00439-007-0436-x 10.1161/01.CIR.0000070949.76608.E2 10.1593/neo.06376 10.1097/00075197-200405000-00002 10.1136/jmg.2003.014118 10.1056/NEJM200412093512423 10.2214/AJR.05.0167 10.1002/1097-0142(20001025)90:5<273::AID-CNCR2>3.0.CO;2-M 10.1159/000066316 10.1111/j.1600-0676.1992.tb00579.x 10.1053/crad.2001.0747 10.1038/modpathol.2009.13 10.1006/jmbi.1999.3429 10.1097/PAS.0b013e318158142f 10.1086/340256 10.1038/nm1440 10.1136/jmg.2006.041723 10.1002/humu.10220 10.1002/bies.20304 10.2337/diabetes.54.12.3577 10.1002/(SICI)1096-8628(19990702)85:1<76::AID-AJMG12>3.0.CO;2-Z 10.1111/j.1399-0004.2006.00700.x 10.1002/1097-0142(19900501)65:9<1985::AID-CNCR2820650918>3.0.CO;2-C 10.1016/S0925-4773(01)00491-9 10.1002/humu.9233 10.1007/s00418-006-0162-9 10.1542/peds.2006-2686 10.1111/j.1399-0004.1980.tb00109.x 10.1038/77053 10.1111/j.1365-2559.2005.02316.x |
| ContentType | Journal Article |
| Copyright | Copyright © 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. 2009 INIST-CNRS |
| Copyright_xml | – notice: Copyright © 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. – notice: 2009 INIST-CNRS |
| DBID | FBQ BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7S9 L.6 7X8 |
| DOI | 10.1002/path.2538 |
| DatabaseName | AGRIS Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE AGRICOLA |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1096-9896 |
| EndPage | 171 |
| ExternalDocumentID | 19334051 21426833 10_1002_path_2538 PATH2538 ark_67375_WNG_P0W0FLLX_P US201301632185 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Finland |
| GeographicLocations_xml | – name: Finland |
| GrantInformation_xml | – fundername: Finnish Foundation for Paediatric Research, Finska Läkaresällskapet funderid: TYH 3304 |
| GroupedDBID | --- -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 123 1KJ 1L6 1OB 1OC 1ZS 29L 31~ 33P 3O- 3SF 3UE 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAVGM AAXRX AAZKR ABCQN ABCUV ABEML ABHUG ABIJN ABJNI ABLJU ABWRO ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACSCC ACSMX ACXBN ACXME ACXQS ADAWD ADBBV ADBTR ADDAD ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEQTP AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFVGU AFZJQ AGJLS AHMBA AI. AIACR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN F00 F01 F04 F5P FBQ FEDTE FUBAC G-S G.N GNP GODZA GSXLS H.X HBH HF~ HHY HHZ HVGLF HZ~ IX1 J0M J5H JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M68 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MVM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OHT OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RX1 SAMSI SUPJJ SV3 TEORI UB1 V2E VH1 W8V W99 WBKPD WH7 WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 XPP XV2 YQI YQJ ZA5 ZGI ZXP ZZTAW ~IA ~KM ~WT AAHQN AAIPD AAMMB AAMNL AANHP AAYCA ABQWH ACRPL ACYXJ ADNMO AEFGJ AEYWJ AFWVQ AGHNM AGQPQ AGXDD AGYGG AHBTC AIDQK AIDYY AIQQE AITYG ALVPJ BSCLL HGLYW OIG AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7S9 L.6 7X8 |
| ID | FETCH-LOGICAL-c4468-36932a3fb151104ffb87dcea8b1fe96fbf568f8ec9fbb9481a39d49d3d6f5b123 |
| IEDL.DBID | DR2 |
| ISSN | 0022-3417 1096-9896 |
| IngestDate | Fri Jul 11 10:04:27 EDT 2025 Fri Jul 11 15:28:48 EDT 2025 Mon Jul 21 06:02:18 EDT 2025 Mon Jul 21 09:14:33 EDT 2025 Wed Oct 01 04:57:54 EDT 2025 Thu Apr 24 22:55:57 EDT 2025 Thu Sep 25 07:34:21 EDT 2025 Sun Sep 21 06:30:16 EDT 2025 Wed Dec 27 19:21:49 EST 2023 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Ubiquitin ubiquitin-proteosome pathway Cardiovascular disease Hepatic disease hereditary tumours Angiomatosis Mulibrey nanism Hereditary Vascular disease Angioma Anatomic pathology Digestive diseases Frequency Tumor Peliosis TRIM37 |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4468-36932a3fb151104ffb87dcea8b1fe96fbf568f8ec9fbb9481a39d49d3d6f5b123 |
| Notes | http://dx.doi.org/10.1002/path.2538 Finnish Foundation for Paediatric Research, Finska Läkaresällskapet - No. TYH 3304 ArticleID:PATH2538 No conflicts of interest were declared. istex:ACCE3D484EB01680FA4F44021489F308C72E8096 ark:/67375/WNG-P0W0FLLX-P ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 19334051 |
| PQID | 46278513 |
| PQPubID | 24069 |
| PageCount | 9 |
| ParticipantIDs | proquest_miscellaneous_67224515 proquest_miscellaneous_46278513 pubmed_primary_19334051 pascalfrancis_primary_21426833 crossref_citationtrail_10_1002_path_2538 crossref_primary_10_1002_path_2538 wiley_primary_10_1002_path_2538_PATH2538 istex_primary_ark_67375_WNG_P0W0FLLX_P fao_agris_US201301632185 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | June 2009 |
| PublicationDateYYYYMMDD | 2009-06-01 |
| PublicationDate_xml | – month: 06 year: 2009 text: June 2009 |
| PublicationDecade | 2000 |
| PublicationPlace | Chichester, UK |
| PublicationPlace_xml | – name: Chichester, UK – name: Chichester – name: England |
| PublicationTitle | The Journal of pathology |
| PublicationTitleAlternate | J. Pathol |
| PublicationYear | 2009 |
| Publisher | John Wiley & Sons, Ltd Wiley |
| Publisher_xml | – name: John Wiley & Sons, Ltd – name: Wiley |
| References | Karlberg S, Lipsanen-Nyman M, Lassus H, Kallijärvi J, Lehesjoki A-E, Butzow R. Gynecological tumors in Mulibery nanism and role for RING finger protein TRIM37 in the pathogenesis of ovarian fribrothecomas. Mod Pathol 2009; in press. Jung CR, Hwang KS, Yoo J, Cho WK, Kim JM, Im DS. E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis. Nat Med 2006; 12: 809-816. Wessels MW, De Graaf BM, Cohen-Overbeek TE, Spitaels SE, de Groot-de Laat LE, Ten Cate FJ, et al. A new syndrome with noncompaction cardiomyopathy, bradycardia, pulmonary stenosis, atrial septal defect and heterotaxy with suggestive linkage to chromosome 6p. Hum Genet 2008; 122: 595-603. Karlberg S, Tiitinen A, Lipsanen-Nyman M. Failure of sexual maturation in mulibrey nanism: N Engl J Med 2004; 351: 2559-2560. Finsterer J, Stöllberger C, Feichtinger H. Histopathological appearance of left ventricular hypertrabeculation/noncompaction. Cardiology 2002; 98: 162-164. Iannaccone R, Federle MP, Brancatelli G, Matsui O, Fishman EK, Narra VR, et al. Peliosis hepatis: spectrum of imaging findings. Am J Roentgenol 2006; 187: 43-52. Hämäläinen RH, Avela K, Lambert J, Kallijärvi J, Eyaid W, Gronau J, et al. Genomic structure and novel mutations in the TRIM37 gene in mulibrey nanism. Hum Mutat 2004; 23: 522-544. Tsokos M, Erbersdobler A. Pathology of peliosis. For Sci Int 2005; 149: 25-33. Karlberg N, Jalanko H, Perheentupa J, Lipsanen-Nyman M. Mulibrey nanism: clinical features and diagnostic criteria. J Med Genet 2004; 41: 92-98. Kallijärvi J, Lahtinen U, Hämäläinen R, Lipsanen-Nyman M, Palvimo JJ, Lehesjoki A-E. TRIM37 defective in mulibrey nanism is a novel RING finger ubiquitin E3 ligase. Exp Cell Res 2005; 308: 146-155. Lipsanen-Nyman M, Perheentupa J, Rapola J, Sovijärvi A, Kupari M. Mulibrey heart disease: clinical manifestations, long-term course and results of pericardiectomy in a series of 49 patients born before 1985. Circulation 2003; 107: 2810-2815. Semanová E, Bartsch O. Mulibrey nanism and Wilms tumour. Am J Med Genet 1999; 85: 76-78. Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CDE31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 2006; 54: 385-395. Tattersall DJ, Moore NR. von Hippel-Lindau disease: MRI of abdominal manifestations. Clin Radiol 2002; 57: 85-92. Similä S, Timonen M, Heikkinen E. A case of mulibrey nanism with associated Wilms' tumor. Clin Genet 1980; 17: 29-30. Kallijärvi J, Avela K, Lipsanen-Nyman M, Ulmanen I, Lehesjoki A-E. The TRIM37 gene encodes a peroxisomal RING-B-box-coiled-coil protein: classification of mulibrey nanism as a new peroxisomal disorder. Am J Hum Genet 2002; 70: 1215-1228. Hämäläinen RH, Mowat D, Gabbett MT, O'Brein TA, Kallijärvi J, Lehesjoki AE. Wilms' tumuor and novel TRIM37 mutations in an Australian patient with mulibrey nanism. Clin Genet 2006; 70: 473-479. Jagiello P, Hammans C, Wieczorek S, Arning L, Stefanski A, Strehl H, et al. A novel splice site mutation in the TRIM37 gene causes mulibrey nanism in a Turkish family with phenotypic heterogeneity. Hum Mutat 2003; 21: 630-635. Scott RH, Stiller CA, Walker L, Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet 2006; 43: 705-715. Kallijärvi J, Hämäläinen RH, Karlberg N, Sainio K, Lehesjoki AE. Tissue expression of the mulibrey nanism-associated Trim37 protein in embryonic and adult mouse tissues. Histochem Cell Biol 2006; 126: 325-334. Borden KL. RING domains: master builders of molecular scaffolds? J Mol Biol 2000; 295: 1103-1112. Karlberg N, Jalanko H, Kallijärvi J, Lehesjoki AE, Lipsanen-Nyman M. Insulin resistance syndrome in subjects with mutated RING finger protein TRIM37. Diabetes 2005; 54: 3577-3581. Haratake J, Scheuer PJ. An immunohistochemical and ultrastructural study of the sinusoids of hepatocellular carcinoma. Cancer 1990; 65: 1985-1993. de Boer WB, Segal A, Frost FA, Sterrett GF. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies. Cancer 2000; 90: 273-278. Dhillon AP, Colombari R, Savage K, Scheuer PJ. An immunohistochemical study of blood vessels within primary hepatocellular tumours. Liver 1992; 12: 311-318. Sun Y. E3 ubiquitin ligases as cancer targets and biomarkers. Neoplasia 2006; 8: 645-654. Rome S, Meugnier E, Vidal H. The ubiquitin-proteasome pathway is a new partner for the control of insulin signalling. Curr Opin Clin Nut Metab Care 2004; 7: 249-254. Avela K, Lipsanen-Nyman M, Perheentupa J, Wallgren-Pettersson C, Marchand S, Fauré S, et al. Assignment of the mulibrey nanism gene to 17q by linkage and linkage-disequilibrium analysis. Am J Hum Genet 1997; 60: 896-902. Cummings GR, Kerr D, Ferguson CC. Constrictive pericarditis with dwarfism in two siblings (mulibrey nanism). J Pediatr 1976; 88: 569-572. Karlberg N, Jalanko H, Lipsanen-Nyman M. Growth and growth hormone therapy in subjects with mulibrey nanism. Pediatrics 2007; 120: e102-111. Hornick JL, Fletcher CDM. PEComa: what do we know so far? Histopathology 2006; 48: 75-82. Avela K, Lipsanen-Nyman M, Idänheimo N, Seemanova E, Rosengren S, Mäkelä TP, et al. Gene encoding a new RING-B-box-coiled-coil protein is mutated in mulibrey nanism. Nat Genet 2000; 25: 298-301. Lehesjoki A-E, Reed VA, Mark Gardiner R, Greene ND. Expression of MUL, a gene encoding a novel RBCC family ring-finger protein, in human and mouse embryogenesis. Mech Dev 2001; 108: 221-225. Meroni G, Diez-Roux G. TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. Bioessays 2005; 27: 1147-1157. Coston WM, Loera S, Lau SK, Ishizawa S, Jiang Z, Wu CL, et al. Distinction of hepatocellular carcinoma from benign hepatic mimicers using Glypican-3 and CD34 immunohistochemistry: Am J Surg Pathol 2008; 32: 433-444. 2006; 70 2004; 41 1997; 60 1976; 88 2000; 25 2006; 12 2006; 54 2004; 7 2002; 57 2004; 23 2002; 98 2007; 120 2009 2006; 8 1997 2000; 295 2008; 32 2000; 90 1999; 85 2001; 108 2005; 27 2008; 122 1992; 12 1980; 17 2004; 351 1990; 65 2003; 107 2006; 43 2005; 149 2006; 48 2006; 187 2005; 308 2005; 54 2002; 70 2006; 126 2003; 21 e_1_2_6_31_2 e_1_2_6_30_2 Tsokos M (e_1_2_6_22_2) 2005; 149 e_1_2_6_18_2 e_1_2_6_19_2 e_1_2_6_12_2 e_1_2_6_13_2 e_1_2_6_34_2 e_1_2_6_10_2 e_1_2_6_33_2 e_1_2_6_11_2 e_1_2_6_32_2 e_1_2_6_16_2 e_1_2_6_17_2 e_1_2_6_14_2 e_1_2_6_37_2 e_1_2_6_15_2 e_1_2_6_36_2 e_1_2_6_20_2 e_1_2_6_8_2 e_1_2_6_7_2 e_1_2_6_9_2 e_1_2_6_29_2 e_1_2_6_4_2 e_1_2_6_6_2 e_1_2_6_5_2 Lack EE (e_1_2_6_35_2) 1997 e_1_2_6_24_2 e_1_2_6_23_2 e_1_2_6_2_2 Avela K (e_1_2_6_3_2) 1997; 60 e_1_2_6_21_2 e_1_2_6_28_2 e_1_2_6_27_2 e_1_2_6_26_2 e_1_2_6_25_2 19347900 - J Pathol. 2009 Jun;218(2):143-5 |
| References_xml | – reference: Kallijärvi J, Hämäläinen RH, Karlberg N, Sainio K, Lehesjoki AE. Tissue expression of the mulibrey nanism-associated Trim37 protein in embryonic and adult mouse tissues. Histochem Cell Biol 2006; 126: 325-334. – reference: Hämäläinen RH, Mowat D, Gabbett MT, O'Brein TA, Kallijärvi J, Lehesjoki AE. Wilms' tumuor and novel TRIM37 mutations in an Australian patient with mulibrey nanism. Clin Genet 2006; 70: 473-479. – reference: Avela K, Lipsanen-Nyman M, Perheentupa J, Wallgren-Pettersson C, Marchand S, Fauré S, et al. Assignment of the mulibrey nanism gene to 17q by linkage and linkage-disequilibrium analysis. Am J Hum Genet 1997; 60: 896-902. – reference: Karlberg S, Tiitinen A, Lipsanen-Nyman M. Failure of sexual maturation in mulibrey nanism: N Engl J Med 2004; 351: 2559-2560. – reference: Karlberg S, Lipsanen-Nyman M, Lassus H, Kallijärvi J, Lehesjoki A-E, Butzow R. Gynecological tumors in Mulibery nanism and role for RING finger protein TRIM37 in the pathogenesis of ovarian fribrothecomas. Mod Pathol 2009; in press. – reference: Lipsanen-Nyman M, Perheentupa J, Rapola J, Sovijärvi A, Kupari M. Mulibrey heart disease: clinical manifestations, long-term course and results of pericardiectomy in a series of 49 patients born before 1985. Circulation 2003; 107: 2810-2815. – reference: Iannaccone R, Federle MP, Brancatelli G, Matsui O, Fishman EK, Narra VR, et al. Peliosis hepatis: spectrum of imaging findings. Am J Roentgenol 2006; 187: 43-52. – reference: Avela K, Lipsanen-Nyman M, Idänheimo N, Seemanova E, Rosengren S, Mäkelä TP, et al. Gene encoding a new RING-B-box-coiled-coil protein is mutated in mulibrey nanism. Nat Genet 2000; 25: 298-301. – reference: Haratake J, Scheuer PJ. An immunohistochemical and ultrastructural study of the sinusoids of hepatocellular carcinoma. Cancer 1990; 65: 1985-1993. – reference: Sun Y. E3 ubiquitin ligases as cancer targets and biomarkers. Neoplasia 2006; 8: 645-654. – reference: Jung CR, Hwang KS, Yoo J, Cho WK, Kim JM, Im DS. E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis. Nat Med 2006; 12: 809-816. – reference: Lehesjoki A-E, Reed VA, Mark Gardiner R, Greene ND. Expression of MUL, a gene encoding a novel RBCC family ring-finger protein, in human and mouse embryogenesis. Mech Dev 2001; 108: 221-225. – reference: Meroni G, Diez-Roux G. TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. Bioessays 2005; 27: 1147-1157. – reference: Wessels MW, De Graaf BM, Cohen-Overbeek TE, Spitaels SE, de Groot-de Laat LE, Ten Cate FJ, et al. A new syndrome with noncompaction cardiomyopathy, bradycardia, pulmonary stenosis, atrial septal defect and heterotaxy with suggestive linkage to chromosome 6p. Hum Genet 2008; 122: 595-603. – reference: Finsterer J, Stöllberger C, Feichtinger H. Histopathological appearance of left ventricular hypertrabeculation/noncompaction. Cardiology 2002; 98: 162-164. – reference: Karlberg N, Jalanko H, Lipsanen-Nyman M. Growth and growth hormone therapy in subjects with mulibrey nanism. Pediatrics 2007; 120: e102-111. – reference: de Boer WB, Segal A, Frost FA, Sterrett GF. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies. Cancer 2000; 90: 273-278. – reference: Tattersall DJ, Moore NR. von Hippel-Lindau disease: MRI of abdominal manifestations. Clin Radiol 2002; 57: 85-92. – reference: Cummings GR, Kerr D, Ferguson CC. Constrictive pericarditis with dwarfism in two siblings (mulibrey nanism). J Pediatr 1976; 88: 569-572. – reference: Rome S, Meugnier E, Vidal H. The ubiquitin-proteasome pathway is a new partner for the control of insulin signalling. Curr Opin Clin Nut Metab Care 2004; 7: 249-254. – reference: Jagiello P, Hammans C, Wieczorek S, Arning L, Stefanski A, Strehl H, et al. A novel splice site mutation in the TRIM37 gene causes mulibrey nanism in a Turkish family with phenotypic heterogeneity. Hum Mutat 2003; 21: 630-635. – reference: Scott RH, Stiller CA, Walker L, Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet 2006; 43: 705-715. – reference: Kallijärvi J, Avela K, Lipsanen-Nyman M, Ulmanen I, Lehesjoki A-E. The TRIM37 gene encodes a peroxisomal RING-B-box-coiled-coil protein: classification of mulibrey nanism as a new peroxisomal disorder. Am J Hum Genet 2002; 70: 1215-1228. – reference: Dhillon AP, Colombari R, Savage K, Scheuer PJ. An immunohistochemical study of blood vessels within primary hepatocellular tumours. Liver 1992; 12: 311-318. – reference: Karlberg N, Jalanko H, Perheentupa J, Lipsanen-Nyman M. Mulibrey nanism: clinical features and diagnostic criteria. J Med Genet 2004; 41: 92-98. – reference: Hämäläinen RH, Avela K, Lambert J, Kallijärvi J, Eyaid W, Gronau J, et al. Genomic structure and novel mutations in the TRIM37 gene in mulibrey nanism. Hum Mutat 2004; 23: 522-544. – reference: Tsokos M, Erbersdobler A. Pathology of peliosis. For Sci Int 2005; 149: 25-33. – reference: Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CDE31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 2006; 54: 385-395. – reference: Coston WM, Loera S, Lau SK, Ishizawa S, Jiang Z, Wu CL, et al. Distinction of hepatocellular carcinoma from benign hepatic mimicers using Glypican-3 and CD34 immunohistochemistry: Am J Surg Pathol 2008; 32: 433-444. – reference: Similä S, Timonen M, Heikkinen E. A case of mulibrey nanism with associated Wilms' tumor. Clin Genet 1980; 17: 29-30. – reference: Semanová E, Bartsch O. Mulibrey nanism and Wilms tumour. Am J Med Genet 1999; 85: 76-78. – reference: Hornick JL, Fletcher CDM. PEComa: what do we know so far? Histopathology 2006; 48: 75-82. – reference: Kallijärvi J, Lahtinen U, Hämäläinen R, Lipsanen-Nyman M, Palvimo JJ, Lehesjoki A-E. TRIM37 defective in mulibrey nanism is a novel RING finger ubiquitin E3 ligase. Exp Cell Res 2005; 308: 146-155. – reference: Karlberg N, Jalanko H, Kallijärvi J, Lehesjoki AE, Lipsanen-Nyman M. Insulin resistance syndrome in subjects with mutated RING finger protein TRIM37. Diabetes 2005; 54: 3577-3581. – reference: Borden KL. RING domains: master builders of molecular scaffolds? J Mol Biol 2000; 295: 1103-1112. – volume: 70 start-page: 1215 year: 2002 end-page: 1228 article-title: The gene encodes a peroxisomal RING‐B‐box‐coiled‐coil protein: classification of mulibrey nanism as a new peroxisomal disorder publication-title: Am J Hum Genet – volume: 48 start-page: 75 year: 2006 end-page: 82 article-title: PEComa: what do we know so far? publication-title: Histopathology – volume: 98 start-page: 162 year: 2002 end-page: 164 article-title: Histopathological appearance of left ventricular hypertrabeculation/noncompaction publication-title: Cardiology – volume: 90 start-page: 273 year: 2000 end-page: 278 article-title: Can CD34 discriminate between benign and malignant hepatocytic lesions in fine‐needle aspirates and thin core biopsies publication-title: Cancer – start-page: 725 year: 1997 end-page: 769 – volume: 351 start-page: 2559 year: 2004 end-page: 2560 article-title: Failure of sexual maturation in mulibrey nanism: publication-title: N Engl J Med – volume: 27 start-page: 1147 year: 2005 end-page: 1157 article-title: TRIM/RBCC, a novel class of ‘single protein RING finger’ E3 ubiquitin ligases publication-title: Bioessays – volume: 21 start-page: 630 year: 2003 end-page: 635 article-title: A novel splice site mutation in the gene causes mulibrey nanism in a Turkish family with phenotypic heterogeneity publication-title: Hum Mutat – volume: 25 start-page: 298 year: 2000 end-page: 301 article-title: Gene encoding a new RING‐B‐box‐coiled‐coil protein is mutated in mulibrey nanism publication-title: Nat Genet – volume: 122 start-page: 595 year: 2008 end-page: 603 article-title: A new syndrome with noncompaction cardiomyopathy, bradycardia, pulmonary stenosis, atrial septal defect and heterotaxy with suggestive linkage to chromosome 6p publication-title: Hum Genet – volume: 70 start-page: 473 year: 2006 end-page: 479 article-title: Wilms' tumuor and novel mutations in an Australian patient with mulibrey nanism publication-title: Clin Genet – volume: 12 start-page: 809 year: 2006 end-page: 816 article-title: E2‐EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis publication-title: Nat Med – volume: 23 start-page: 522 year: 2004 end-page: 544 article-title: Genomic structure and novel mutations in the gene in mulibrey nanism publication-title: Hum Mutat – volume: 12 start-page: 311 year: 1992 end-page: 318 article-title: An immunohistochemical study of blood vessels within primary hepatocellular tumours publication-title: Liver – volume: 57 start-page: 85 year: 2002 end-page: 92 article-title: von Hippel–Lindau disease: MRI of abdominal manifestations publication-title: Clin Radiol – volume: 88 start-page: 569 year: 1976 end-page: 572 article-title: Constrictive pericarditis with dwarfism in two siblings (mulibrey nanism) publication-title: J Pediatr – year: 2009 article-title: Gynecological tumors in Mulibery nanism and role for RING finger protein TRIM37 in the pathogenesis of ovarian fribrothecomas publication-title: Mod Pathol – volume: 60 start-page: 896 year: 1997 end-page: 902 article-title: Assignment of the mulibrey nanism gene to 17q by linkage and linkage‐disequilibrium analysis publication-title: Am J Hum Genet – volume: 308 start-page: 146 year: 2005 end-page: 155 article-title: TRIM37 defective in mulibrey nanism is a novel RING finger ubiquitin E3 ligase publication-title: Exp Cell Res – volume: 108 start-page: 221 year: 2001 end-page: 225 article-title: Expression of , a gene encoding a novel RBCC family ring‐finger protein, in human and mouse embryogenesis publication-title: Mech Dev – volume: 54 start-page: 385 year: 2006 end-page: 395 article-title: Immunohistochemical expression of endothelial markers CDE31, CD34, von Willebrand factor, and Fli‐1 in normal human tissues publication-title: J Histochem Cytochem – volume: 120 start-page: e102 year: 2007 end-page: 111 article-title: Growth and growth hormone therapy in subjects with mulibrey nanism publication-title: Pediatrics – volume: 32 start-page: 433 year: 2008 end-page: 444 article-title: Distinction of hepatocellular carcinoma from benign hepatic mimicers using Glypican‐3 and CD34 immunohistochemistry: publication-title: Am J Surg Pathol – volume: 295 start-page: 1103 year: 2000 end-page: 1112 article-title: RING domains: master builders of molecular scaffolds? publication-title: J Mol Biol – volume: 85 start-page: 76 year: 1999 end-page: 78 article-title: Mulibrey nanism and Wilms tumour publication-title: Am J Med Genet – volume: 65 start-page: 1985 year: 1990 end-page: 1993 article-title: An immunohistochemical and ultrastructural study of the sinusoids of hepatocellular carcinoma publication-title: Cancer – volume: 41 start-page: 92 year: 2004 end-page: 98 article-title: Mulibrey nanism: clinical features and diagnostic criteria publication-title: J Med Genet – volume: 43 start-page: 705 year: 2006 end-page: 715 article-title: Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour publication-title: J Med Genet – volume: 149 start-page: 25 year: 2005 end-page: 33 article-title: Pathology of peliosis publication-title: For Sci Int – volume: 187 start-page: 43 year: 2006 end-page: 52 article-title: Peliosis hepatis: spectrum of imaging findings publication-title: Am J Roentgenol – volume: 126 start-page: 325 year: 2006 end-page: 334 article-title: Tissue expression of the mulibrey nanism‐associated Trim37 protein in embryonic and adult mouse tissues publication-title: Histochem Cell Biol – volume: 7 start-page: 249 year: 2004 end-page: 254 article-title: The ubiquitin–proteasome pathway is a new partner for the control of insulin signalling publication-title: Curr Opin Clin Nut Metab Care – volume: 54 start-page: 3577 year: 2005 end-page: 3581 article-title: Insulin resistance syndrome in subjects with mutated RING finger protein TRIM37 publication-title: Diabetes – volume: 17 start-page: 29 year: 1980 end-page: 30 article-title: A case of mulibrey nanism with associated Wilms' tumor publication-title: Clin Genet – volume: 107 start-page: 2810 year: 2003 end-page: 2815 article-title: Mulibrey heart disease: clinical manifestations, long‐term course and results of pericardiectomy in a series of 49 patients born before 1985 publication-title: Circulation – volume: 8 start-page: 645 year: 2006 end-page: 654 article-title: E3 ubiquitin ligases as cancer targets and biomarkers publication-title: Neoplasia – ident: e_1_2_6_8_2 doi: 10.1016/j.yexcr.2005.04.001 – volume: 149 start-page: 25 year: 2005 ident: e_1_2_6_22_2 article-title: Pathology of peliosis publication-title: For Sci Int – ident: e_1_2_6_10_2 doi: 10.1016/S0022-3476(76)80008-X – ident: e_1_2_6_23_2 doi: 10.1369/jhc.4A6514.2005 – ident: e_1_2_6_37_2 doi: 10.1007/s00439-007-0436-x – ident: e_1_2_6_15_2 doi: 10.1161/01.CIR.0000070949.76608.E2 – ident: e_1_2_6_30_2 doi: 10.1593/neo.06376 – ident: e_1_2_6_31_2 doi: 10.1097/00075197-200405000-00002 – ident: e_1_2_6_2_2 doi: 10.1136/jmg.2003.014118 – ident: e_1_2_6_17_2 doi: 10.1056/NEJM200412093512423 – ident: e_1_2_6_21_2 doi: 10.2214/AJR.05.0167 – ident: e_1_2_6_27_2 doi: 10.1002/1097-0142(20001025)90:5<273::AID-CNCR2>3.0.CO;2-M – ident: e_1_2_6_36_2 doi: 10.1159/000066316 – ident: e_1_2_6_26_2 doi: 10.1111/j.1600-0676.1992.tb00579.x – ident: e_1_2_6_34_2 doi: 10.1053/crad.2001.0747 – ident: e_1_2_6_20_2 doi: 10.1038/modpathol.2009.13 – ident: e_1_2_6_9_2 doi: 10.1006/jmbi.1999.3429 – ident: e_1_2_6_24_2 doi: 10.1097/PAS.0b013e318158142f – ident: e_1_2_6_5_2 doi: 10.1086/340256 – ident: e_1_2_6_33_2 doi: 10.1038/nm1440 – ident: e_1_2_6_32_2 doi: 10.1136/jmg.2006.041723 – ident: e_1_2_6_11_2 doi: 10.1002/humu.10220 – ident: e_1_2_6_29_2 doi: 10.1002/bies.20304 – ident: e_1_2_6_16_2 doi: 10.2337/diabetes.54.12.3577 – ident: e_1_2_6_19_2 doi: 10.1002/(SICI)1096-8628(19990702)85:1<76::AID-AJMG12>3.0.CO;2-Z – start-page: 725 volume-title: Urologic Surgical Pathology year: 1997 ident: e_1_2_6_35_2 – ident: e_1_2_6_13_2 doi: 10.1111/j.1399-0004.2006.00700.x – ident: e_1_2_6_25_2 doi: 10.1002/1097-0142(19900501)65:9<1985::AID-CNCR2820650918>3.0.CO;2-C – ident: e_1_2_6_6_2 doi: 10.1016/S0925-4773(01)00491-9 – ident: e_1_2_6_12_2 doi: 10.1002/humu.9233 – ident: e_1_2_6_7_2 doi: 10.1007/s00418-006-0162-9 – ident: e_1_2_6_14_2 doi: 10.1542/peds.2006-2686 – ident: e_1_2_6_18_2 doi: 10.1111/j.1399-0004.1980.tb00109.x – ident: e_1_2_6_4_2 doi: 10.1038/77053 – volume: 60 start-page: 896 year: 1997 ident: e_1_2_6_3_2 article-title: Assignment of the mulibrey nanism gene to 17q by linkage and linkage‐disequilibrium analysis publication-title: Am J Hum Genet – ident: e_1_2_6_28_2 doi: 10.1111/j.1365-2559.2005.02316.x – reference: 19347900 - J Pathol. 2009 Jun;218(2):143-5 |
| SSID | ssj0009955 |
| Score | 2.1339142 |
| Snippet | Mulibrey nanism (MUL) is a monogenic disorder with prenatal-onset growth failure, typical clinical characteristics, cardiopathy and tendency for a metabolic... Mulibrey nanism (MUL) is a monogenic disorder with prenatal‐onset growth failure, typical clinical characteristics, cardiopathy and tendency for a metabolic... |
| SourceID | proquest pubmed pascalfrancis crossref wiley istex fao |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 163 |
| SubjectTerms | Adolescent Adrenal Gland Neoplasms - complications Adrenal Gland Neoplasms - pathology Adult Aged Biological and medical sciences Child Child, Preschool Cohort Studies Female Finland Heart Neoplasms - complications Heart Neoplasms - pathology hereditary tumours Humans Infant Investigative techniques, diagnostic techniques (general aspects) Kidney Neoplasms - complications Kidney Neoplasms - pathology Liver Neoplasms - complications Liver Neoplasms - pathology Lung Neoplasms - complications Lung Neoplasms - pathology Male Medical sciences Middle Aged Mulibrey nanism Mulibrey Nanism - complications Mulibrey Nanism - pathology Neoplasms - complications Neoplasms - pathology Pancreatic Neoplasms - complications Pancreatic Neoplasms - pathology Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques peliosis Prevalence Thyroid Neoplasms - complications Thyroid Neoplasms - pathology TRIM37 ubiquitin-proteosome pathway Wilms Tumor - complications Wilms Tumor - pathology |
| Title | High frequency of tumours in Mulibrey nanism |
| URI | https://api.istex.fr/ark:/67375/WNG-P0W0FLLX-P/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpath.2538 https://www.ncbi.nlm.nih.gov/pubmed/19334051 https://www.proquest.com/docview/46278513 https://www.proquest.com/docview/67224515 |
| Volume | 218 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0022-3417 databaseCode: DR2 dateStart: 19960101 customDbUrl: isFulltext: true eissn: 1096-9896 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009955 providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6VHhAX3lDzKBZCiANJbe_Da3GqECFCTRVBo-aAtNpd71ZVqYPiRKL8embsxFFQQYibDzOH2ZnZ_bwz-w3Aq5Knhc1L13OBnuQ4zHQVeN6TwiWZU1wwTxXd0bEcTvinqZjuwLv1W5iWH6K7cKPMaPZrSnBj64MNaShN7O1nmK-4_6ZMNCXazxvqqKIQomMK52m-ZhVKsoNOc-ssuhHMDBEqLe4P6pA0NS5SaKdbXAc_t9FscxwN7sDXtSFtF8pFf7mwfffzN47H_7T0LtxewdT4sI2re7Djq_twc7QqxD-At9QfEod524h9Fc9CvFheolYdn1fxqGm58ldxZarz-vIhTAYfTt4Pe6vBCz3H6SUWk4jqDAsW4QD-roVgFbrTG2XT4AsZbBBSBeVdEawluhfDipIXJStlEBbPwkewW80qvwdxqqwyGS9zj473CTc2lUXmuWMhV9KYCN6sXaDdipWchmN80y2fcqbJek3WR_CyE_3eUnFcJ7SHftTmDLdIPfmSUWEWIScCGRHB68a5nbKZX1BbWy706fFHPU5Ok8HR0VSPI9jf8n6nQPR0UjEWwYt1OGjMRiqxmMrPlrXmMssRw_5FQuYImhBERvC4jaONLQVjCJ9TXJImGv5spB4fngzp48m_iz6FW20hjC6QnsHuYr70zxFPLex-kzi_AGYSGRc |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED9tQwJe-IaFjy1CCPFAuyR2HEfiZQJKgbaqoNX6gizbsdE0lqJ-SIy_nrukTVU0EOItD3cP57uzf_GdfwfwrOBxbrLCtqynJzkWM116nrVEaqPESp4yRxXd_kB0x_zDJJ3swKv1W5iaH6K5cKPMqPZrSnC6kD7asIbSyN52ggm7C1eoPkdp-ebThjwqz9O04QrncbbmFYqSo0Z16zTa9XqKGJWW9wf1SOo5LpOv51tcBkC38Wx1IHVuwpe1KXUfyll7uTBt-_M3lsf_tfUW3Fgh1fC4Dq3bsOPKO3C1v6rF34WX1CIS-lndi30RTn24WJ6j1jw8LcN-1XXlLsJSl6fz83sw7rwdve62VrMXWpbTYywmENhp5g0iAvxj895I9KjT0sTe5cIbnwrppbO5N4YYXzTLC54XrBA-NXgc3oe9clq6fQhjaaROeJE59L2LuDaxyBPHLfOZFFoH8GLtA2VXxOQ0H-ObqimVE0XWK7I-gKeN6PeajeMyoX10pNJfcZdU488J1WYRdSKWSQN4Xnm3UdazM-psy1J1MninhtFJ1On1JmoYwMGW-xsFYqgTkrEADtfxoDAhqcqiSzddzhUXSYYw9i8SIkPchDgygAd1IG1syRlDBB3jklTh8Gcj1fB41KWPh_8uegjXuqN-T_XeDz4-gut1XYzukx7D3mK2dE8QXi3MQZVFvwDntB0z |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED9tQ5p44RsWPrYIIcQD7ZLYcRzxNAGlQFtVsGp9mGTZjo2msXTqh8T467lL2lRFAyHe8nD3cL47--fc-XcALwoe5yYrbMt6epJjMdOl51lLpDZKrOQpc1TR7Q9Ed8Q_jdPxFrxZvYWp-SGaH26UGdV-TQl-WfjDNWkoTextJ5iv23CDC7xdESL6suaOyvM0bajCeZytaIWi5LBR3TiMtr2eIESl1f1BLZJ6hqvk6_EW1-HPTThbnUed23C6sqRuQzlvL-ambX_-RvL4n6begVtLnBoe1YF1F7ZceQ92-8tK_H14TQ0ioZ_WndhX4cSH88UFas3CszLsVz1X7iosdXk2u3gAo87747fd1nLyQstyeorFBMI6zbxBPID3Ne-NRH86LU3sXS688amQXjqbe2OI70WzvOB5wQrhU4OH4UPYKSel24MwlkbqhBeZQ8-7iGsTizxx3DKfSaF1AK9WLlB2SUtO0zG-q5pQOVFkvSLrA3jeiF7WXBzXCe2hH5X-hnukGn1NqDKLmBORTBrAy8q5jbKenlNfW5aqk8EHNYxOok6vN1bDAPY3vN8oED-dkIwFcLAKB4XpSDUWXbrJYqa4SDIEsX-REBmiJkSRATyq42htS84Y4ucYl6SKhj8bqYZHx136ePzvogewO3zXUb2Pg89P4GZdFKOfSU9hZz5duGeIreZmv8qhX3rEG-I |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+frequency+of+tumours+in+Mulibrey+nanism&rft.jtitle=The+Journal+of+pathology&rft.au=Karlberg%2C+Niklas&rft.au=Karlberg%2C+Susann&rft.au=Karikoski%2C+Riitta&rft.au=Mikkola%2C+Sakari&rft.date=2009-06-01&rft.pub=John+Wiley+%26+Sons%2C+Ltd&rft.issn=0022-3417&rft.eissn=1096-9896&rft.volume=218&rft.issue=2&rft.spage=163&rft.epage=171&rft_id=info:doi/10.1002%2Fpath.2538&rft.externalDocID=US201301632185 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3417&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3417&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3417&client=summon |